By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Meridian Bioscience has submitted a 510(k) application with the US Food and Drug Administration for its illumigene C. difficile molecular diagnostic test.

The illumigene C. difficile test detects and amplifies a pathogenic DNA region of all toxin-producing strains of Clostridium difficile. The test uses a stool sample and can provide results in less than an hour, said Meridian.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.